ALTO vs BMY · P/E 13, rev $470.4M vs P/E 17, rev $24.46B
Alto Ingredients Inc (ALTO) versus Bristol-Myers Squibb Company (BMY) — a side-by-side from cached financials, not a winner call.
Alto Ingredients Inc (ALTO) is a specialty chemicals company listed on NASDAQ.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Latest reported ALTO revenue for 2026-06-30 was $470.4M. Net income was $16.0M. ALTO currently screens at market cap $383.6M and trailing P/E 13.4.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
ALTO currently screens at market cap $383.6M and trailing P/E 13.4. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Not investment advice. Open the ALTO and BMY stock pages for the full models.
Not investment advice.